Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
A J Jacobs, Maggie Harris, Gunter Deppe, Indira Dasgupta, Cohen Cj
Abstract
A J Jacobs, Maggie Harris, Gunter Deppe, Indira Dasgupta, Cohen Cj
Abstract
Four patients were treated with vinblastine, cisplatin, and bleomycin for recurrent or persistent germ cell tumors. In all patients a clinical response was achieved. In 2 patients complete response was attained and they are free of disease following second-look laparotomy. One had a mixed germ cell tumor that persisted as dysgerminoma following primary chemotherapy. The other was a true hermaphrodite with pure dysgerminoma. In patients with endodermal sinus tumor transient response was achieved, but the tumors recurred and the patients died within 6 months.
OpenAlex reports 52 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Four patients were treated with vinblastine, cisplatin, and bleomycin for recurrent or persistent germ cell tumors. In all patients a clinical response was achieved. In 2 patients complete response was attained and they are free of disease following second-look laparotomy. One had a mixed germ cell tumor that persisted as dysgerminoma following primary chemotherapy. The other was a true hermaphrodite with pure dysgerminoma. In patients with endodermal sinus tumor transient response was achieved, but the tumors recurred and the patients died within 6 months.
Key concepts: Vinblastine, Medicine, Bleomycin, Dysgerminoma, Germ cell tumors, Endodermal sinus tumor, Cisplatin, Laparotomy